Alaska HB 216: An Act relating to required disclosures for gene therapy products.

Status: (H) REFERRED TO HEALTH & SOCIAL SERVICES (as of 2024-01-16)

State: Alaska · Session: 33 · Bill: HB 216

Subjects: BUSINESS, DISCLOSURE, DRUGS, FOOD, MEDICAL CARE

Sponsors: Eastman

View Alaska HB 216 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.